Skip to main content
Premium Trial:

Request an Annual Quote

Helix, Medical University of South Carolina Partner for Population Genomics Program

NEW YORK – The Medical University of South Carolina and Helix said Monday that they have partnered to develop a large-scale population genomics initiative in South Carolina called In Our DNA SC.

Beginning this fall, the program will enroll a total of 100,000 patients, providing them with no-cost genetic testing, initially focused on cancer and cardiovascular disease. The goal is to improve healthcare outcomes by integrating genetic insights into both clinical care and research.

Specifically, MUSC intends to use Helix's Sequence Once, Query Often model and end-to-end integration platform to enable the use of genetic insights. Financial terms of the strategic collaboration were not disclosed.

In addition to reporting genetic information to help with individuals' healthcare, the effort will also support the creation of a clinico-genomic dataset from consenting participants. This resource is intended to help researchers discover new disease drivers and develop potential treatments.

The partners also hope the database can lay the groundwork for collaborations with other organizations "across the healthcare value chain."

"Precision medicine is an emerging field that is going to transform the future delivery of healthcare. Being a leader and helping to define this path is core to our mission," David Cole, MUSC's president, said in a statement.

Helix CEO James Lu added that other population genomics efforts have demonstrated the potential to improve a health systems' ability to deliver precision care.

"In similar programs, as many as 1 in 75 participants have been found to be at risk for a serious health issue, of which 90 percent would not have been discovered through traditional practice," he said.

According to MUSC, enrollment will initially be available to patients who sign up at select MUSC clinics and locations, expanding later to participants throughout the community and state via the university's broader clinical affiliates and partners.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.